HK1173373A1 - Method and composition for synchronizing time of insemination - Google Patents

Method and composition for synchronizing time of insemination

Info

Publication number
HK1173373A1
HK1173373A1 HK13100612.3A HK13100612A HK1173373A1 HK 1173373 A1 HK1173373 A1 HK 1173373A1 HK 13100612 A HK13100612 A HK 13100612A HK 1173373 A1 HK1173373 A1 HK 1173373A1
Authority
HK
Hong Kong
Prior art keywords
insemination
composition
synchronizing time
synchronizing
time
Prior art date
Application number
HK13100612.3A
Other languages
English (en)
Chinese (zh)
Inventor
Stephen Kent Webel
Mark E Swanson
Original Assignee
Pennatek Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennatek Llc filed Critical Pennatek Llc
Publication of HK1173373A1 publication Critical patent/HK1173373A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D19/00—Instruments or methods for reproduction or fertilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D19/00—Instruments or methods for reproduction or fertilisation
    • A61D19/02—Instruments or methods for reproduction or fertilisation for artificial insemination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13100612.3A 2009-04-23 2013-01-15 Method and composition for synchronizing time of insemination HK1173373A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17200909P 2009-04-23 2009-04-23
PCT/US2010/032258 WO2010124220A1 (en) 2009-04-23 2010-04-23 Method and composition for synchronizing time of insemination

Publications (1)

Publication Number Publication Date
HK1173373A1 true HK1173373A1 (en) 2013-05-16

Family

ID=43011504

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13100612.3A HK1173373A1 (en) 2009-04-23 2013-01-15 Method and composition for synchronizing time of insemination

Country Status (12)

Country Link
US (5) US8905913B2 (xx)
EP (1) EP2421545B1 (xx)
CN (2) CN102596215B (xx)
BR (2) BR122013009981B1 (xx)
CA (1) CA2758532C (xx)
DK (1) DK2421545T3 (xx)
ES (1) ES2661240T3 (xx)
HK (1) HK1173373A1 (xx)
HU (1) HUE036576T2 (xx)
PL (1) PL2421545T3 (xx)
RU (1) RU2568839C2 (xx)
WO (1) WO2010124220A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035717A2 (en) 2003-10-03 2005-04-21 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
EP2421545B1 (en) 2009-04-23 2017-12-06 JBS United Animal Health II LLC Method and composition for synchronizing time of insemination
MX357275B (es) 2012-06-06 2018-07-03 Mofa Group Llc Envase multi-compartimento para líquidos biológicos.
US9888990B2 (en) 2012-06-06 2018-02-13 Inguran, Llc Methods for use of sex sorted semen to improve genetic management in swine
US9433195B2 (en) 2012-06-06 2016-09-06 Inguran, Llc Methods for increasing genetic progress in a line or breed of swine using sex-selected sperm cells
CN113398243A (zh) * 2012-11-28 2021-09-17 联合动物健康第二有限责任公司 用于同步小母猪的授精时间的方法
WO2015081157A1 (en) * 2013-11-27 2015-06-04 Jbs United Animal Health Ii Llc Method and composition for synchronizing time of insemination in gilts
TW201625218A (zh) * 2014-04-18 2016-07-16 Ｊｂｓ聯合動物保健有限責任公司 製造含ｇｎｒｈ凝膠之方法
CN105409871A (zh) * 2015-11-04 2016-03-23 宁波市三生药业有限公司 后备和经产母猪高效查情及同步受孕方法
CN105815273B (zh) * 2016-03-24 2018-10-09 赤峰家育种猪生态科技集团有限公司 一种恒定生产与目测管理相结合的种猪繁育方法
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
KR20200099550A (ko) 2017-12-13 2020-08-24 텍사스 테크 유니버시티 시스템 성숙기 직전 돼지의 이른 발정 개시를 자극하고 번식에 필요한 노동을 감소시키기 위한 페로몬 조성물 및 사용 방법
CN110495967A (zh) * 2019-08-21 2019-11-26 吉林农业大学 一种同期排卵定时输精的方法

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860701A (en) 1968-04-22 1975-01-14 Searle & Co Method for use and compositions of 11-lower alkyl steroids and drug delivery system for the controlled elution of 11-lower alkyl steroids
AT347054B (de) 1973-09-29 1978-12-11 Takeda Chemical Industries Ltd Verfahren zur herstellung von neuen nonapeptidamid-derivaten
US4005063A (en) 1973-10-11 1977-01-25 Abbott Laboratories [Des-gly]10 -GnRH nonapeptide anide analogs in position 6 having ovulation-inducing activity
US3991750A (en) 1975-04-28 1976-11-16 Syntex Corporation Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals
SU573159A1 (ru) * 1976-03-17 1977-09-25 Всесоюзный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Животноводства Способ синхронизации охоты и овул ции у свиноматок
US4756907A (en) 1978-10-17 1988-07-12 Stolle Research & Development Corp. Active/passive immunization of the internal female reproductive organs
US4732763A (en) 1978-10-17 1988-03-22 Stolle Research And Development Corporation Active/passive immunization of the internal female reproductive organs
JPS5781447A (en) 1980-11-11 1982-05-21 Toyo Jozo Co Ltd Human chorionic gonadotropic hormone c-terminal fragment
GB8428201D0 (en) 1984-11-08 1984-12-19 Glaxo Group Ltd Biological preparations
US4931279A (en) 1985-08-16 1990-06-05 Bausch & Lomb Incorporated Sustained release formulation containing an ion-exchange resin
US4804626A (en) 1986-10-22 1989-02-14 The General Hospital Corporation Immunometric assay for the detection of human chorionic gonadotropin
US4780451B1 (en) 1987-01-23 1995-04-04 Asua International Inc Composition and method for producing superovulation in cattle
US5276022A (en) 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5236704A (en) 1988-01-28 1993-08-17 Sumitomo Pharmaceuticals Co., Ltd. Controlled release formulation
US4975280A (en) 1989-01-23 1990-12-04 Ethyl Corporation Bioerodable sustained release implants
FR2663223B1 (fr) 1990-06-14 1994-12-02 Af Aplicaciones Far Lab Forme galenique parenterale.
US5180711A (en) 1990-06-14 1993-01-19 Applied Research Systems Ars Holding N.V. Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals
US5434136A (en) 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
HU222501B1 (hu) 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
US5444167A (en) 1993-07-07 1995-08-22 Wallac Oy Variant luteinizing hormone encoding DNA
EP0721348B1 (en) 1993-09-29 1999-09-01 Alza Corporation Monoglyceride/lactate ester permeation enhancer
US5650173A (en) 1993-11-19 1997-07-22 Alkermes Controlled Therapeutics Inc. Ii Preparation of biodegradable microparticles containing a biologically active agent
US5688506A (en) 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
FR2717688B1 (fr) 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.
US5747058A (en) 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5589457A (en) 1995-07-03 1996-12-31 Ausa International, Inc. Process for the synchronization of ovulation
GB9514816D0 (en) 1995-07-19 1995-09-20 Ucli Ltd Substances and their medical use
ATE508733T1 (de) 1996-03-04 2011-05-15 Penn State Res Found Materialien und verfahren zur steigerung der zellulären internalisierung
FR2747042B1 (fr) 1996-04-05 1998-06-05 Besins Iscovesco Lab Medicament a base de progesterone et d'oestradiol
AU2827797A (en) 1996-05-30 1998-01-05 Sepracor, Inc. Nsaids for regulating the reproductive cycle of domesticated animals
US6051558A (en) 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
US6028057A (en) 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
FR2776520B1 (fr) 1998-03-25 2000-05-05 Sod Conseils Rech Applic Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
US6087352A (en) 1998-08-17 2000-07-11 Trout; William E. Use of Zeranol to modulate reproductive cycles
EP1117378A2 (en) 1998-10-05 2001-07-25 The Penn State Research Foundation Compositions and methods for enhancing receptor-mediated cellular internalization
WO2000078335A1 (en) 1999-06-18 2000-12-28 Southern Biosystems, Inc. COMPOSITIONS FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS
DE10050831A1 (de) * 2000-10-05 2002-05-02 Veyx Pharma Gmbh Verfahren zum Zyklusstart bei weiblichen Zuchttieren
GB0117057D0 (en) 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
NZ542549A (en) 2003-03-04 2008-11-28 Aspenbio Pharma Inc Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using single-chain luteinizing hormone
US7456207B2 (en) 2003-09-25 2008-11-25 Teva Pharmaceuticals Usa, Inc. Vaginal pharmaceutical compositions and methods for preparing them
WO2005035717A2 (en) 2003-10-03 2005-04-21 Thorn Bioscience, Llc Process for the synchronization of ovulation for timed breeding without heat detection
WO2005041871A2 (en) * 2003-10-24 2005-05-12 Alza Corporation Apparatus and method for enhancing transdermal drug delivery
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
WO2007049157A2 (en) 2005-10-24 2007-05-03 Manawatu Biotech Investments Ltd. (Mbil) Ovulation cycle monitoring and management
US20090036384A1 (en) 2005-12-02 2009-02-05 Parnell Laboratories (Aust) Pty Limited Increasing pregnancy rates
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
EP1891941A1 (en) 2006-08-11 2008-02-27 OctoPlus Technologies B.V. Aqueous gels comprising microspheres
EP2065032A1 (en) 2007-11-27 2009-06-03 Galderma Research & Development A method for producing adapalene gels
EP2421545B1 (en) 2009-04-23 2017-12-06 JBS United Animal Health II LLC Method and composition for synchronizing time of insemination
US20140371317A1 (en) 2012-02-08 2014-12-18 Dow Corning Corporation Silicone Resin Emulsions
CN113398243A (zh) 2012-11-28 2021-09-17 联合动物健康第二有限责任公司 用于同步小母猪的授精时间的方法
WO2015081157A1 (en) 2013-11-27 2015-06-04 Jbs United Animal Health Ii Llc Method and composition for synchronizing time of insemination in gilts
TW201625218A (zh) 2014-04-18 2016-07-16 Ｊｂｓ聯合動物保健有限責任公司 製造含ｇｎｒｈ凝膠之方法

Also Published As

Publication number Publication date
EP2421545A1 (en) 2012-02-29
HUE036576T2 (hu) 2018-07-30
US20120046519A1 (en) 2012-02-23
CN102596215B (zh) 2015-04-29
US8905913B2 (en) 2014-12-09
EP2421545B1 (en) 2017-12-06
US9352011B2 (en) 2016-05-31
BRPI1014362A2 (pt) 2016-04-05
BR122013009981A2 (pt) 2016-05-17
PL2421545T3 (pl) 2018-05-30
CN102596215A (zh) 2012-07-18
EP2421545A4 (en) 2013-05-15
US9757425B2 (en) 2017-09-12
US10668127B2 (en) 2020-06-02
CN104906556A (zh) 2015-09-16
WO2010124220A1 (en) 2010-10-28
US20200345806A1 (en) 2020-11-05
US20180133284A1 (en) 2018-05-17
DK2421545T3 (en) 2018-03-12
US20150057225A1 (en) 2015-02-26
ES2661240T3 (es) 2018-03-28
US20160263180A1 (en) 2016-09-15
CA2758532C (en) 2017-07-25
RU2011147472A (ru) 2013-05-27
BR122013009981B1 (pt) 2020-02-11
RU2568839C2 (ru) 2015-11-20
CA2758532A1 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
HK1173373A1 (en) Method and composition for synchronizing time of insemination
IL250068A0 (en) Method and intermediates for preparing pharmaceutical substances
GB2491757B (en) Method and apparatus for clock synchronization
EP2456160A4 (en) METHOD AND DEVICE FOR TIME SYNCHRONIZATION OF NETWORK GAMES
EP2491514A4 (en) SYSTEM AND METHOD FOR LENDING INTERCONSOMERATING DIGITAL CONTENT
EP2467914A4 (en) SLEEVE SYSTEM AND METHOD FOR USE THEREOF
IL216668A0 (en) Pharmaceutical composition and treatment method for emergrncy contraception
HK1164832A1 (en) Piceatannol-containing composition and method of producing piceatannol- containing composition
PL2213648T3 (pl) Formulacje aldehydo-aminowe oraz sposób ich wytwarzania i stosowania
EP2348778A4 (en) METHOD AND DEVICE FOR TERMINATION OF SYNCHRONIZATIONS
EP2528254A4 (en) PROCESS AND DEVICE FOR TIME SYNCHRONIZATION
PL2391589T3 (pl) Klinkier sulfo-glinowy i sposób jego wytwarzania
GB0912468D0 (en) Composition and method
ZA201202130B (en) Methods and apparatus for synchronization of data frames
PL2434814T3 (pl) Sposób i urządzenie do synchronizacji
HK1172163A1 (zh) 用於減少延緩持續時間的系統和方法
EP2479176A4 (en) PROCESS FOR THE PREPARATION OF ILOPERIDONE AND METHOD FOR ITS CRYSTALLIZATION
HK1174825A1 (en) Composition and method for skin repair
ZA201203060B (en) Composition and method of delivery
EP2618844A4 (en) ORAL FORMABLE COMPOSITION AND METHOD FOR THEIR PRODUCTION AND USE
PL2519939T3 (pl) Sposób, obiekt i ich zastosowanie do mocowania plakatów
EP2385950A4 (en) PROCESS FOR 2-SULFATATION OF GLYCOSIDES
EP2470016A4 (en) SYNERGISTIC COMPOSITION AND METHOD OF USE
IL213955A (en) Method for improved biological activity of pharmaceutical preparations
GB0901667D0 (en) Composition and method

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190421